Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

Abstract Background Identifying and reducing cardiometabolic risks driven by obesity remains a healthcare challenge. The metabolic syndrome is associated with abdominal obesity and inflammation and is predictive of long-term risk of developing type 2 diabetes and cardiovascular disease in otherwise...

Full description

Bibliographic Details
Main Authors: Rasmus M. Sandsdal, Christian R. Juhl, Simon B. K. Jensen, Julie R. Lundgren, Charlotte Janus, Martin B. Blond, Mads Rosenkilde, Adrian F. Bogh, Lasse Gliemann, Jens-Erik B. Jensen, Charalambos Antoniades, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad, Signe S. Torekov
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Cardiovascular Diabetology
Subjects:
Metabolic syndrome
Obesity
Inflammation
Cardiometabolic risk
GLP-1
Exercise
Online Access:https://doi.org/10.1186/s12933-023-01765-z

Internet

https://doi.org/10.1186/s12933-023-01765-z

Similar Items